VEGFA and hematologic disorder: Here we prospectively evaluated the serial expression of sFlt-1 and VEGF-A in patients with hematological malignancies and chemotherapy-related FN, to gain insights about both potential roles of sFlt-1 in patients with febrile neutropenia and sepsis, as a biomarker or as a therapeutic tool.